Literature DB >> 18159350

Bioterrorism in Canada: An economic assessment of prevention and postattack response.

R St John1, B Finlay, C Blair.   

Abstract

The present paper calculates the human and economic consequences of a bioterrorist attack on Canadian soil using aerosolized Bacillus anthracis and Clostridium botulinum. The study assumed that 100,000 people in a Canadian suburban neighbourhood were exposed over a 2 h period to an infectious dose of one of the agents. Using an epidemic curve based on the epidemiology and management of anthrax and botulinum poisoning, the costs of intervention and treatment after an attack were compared with the costs of preparedness before a bioterrorist attack. The results show that an investment in planning and preparedness to manage the consequences of an attack can reduce morbidity, mortality and economic costs. The sooner that an intervention program is instituted, the more significant are the health and economic benefits. The greatest benefits were realized when postattack intervention was initiated before day 3 after the event. The economic impact of a bioterrorist attack in Canada could range from $6.4 billion/100,000 exposed to B anthracis to $8.6 billion/100,000 exposed in an attack using C botulinum. Without the benefit of an effective consequence management program, predicted deaths totalled 32,875 from anthrax and 30,000 from botulinum toxin. Rapid implementation of a postattack prophylaxis program that includes the stockpiling of antibiotics, vaccines and antitoxins; training of first responders in the diagnosis, handling and treatment of pathogens; and the general enhancement of Canada's response capability would reduce both human and economic losses.

Entities:  

Keywords:  Actuarially fair premium; Anthrax; Bioterrorism; Botulinum toxin; Economic consequences

Year:  2001        PMID: 18159350      PMCID: PMC2094836          DOI: 10.1155/2001/904148

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  1 in total

Review 1.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

Authors:  A F Kaufmann; M I Meltzer; G P Schmid
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

  1 in total
  7 in total

1.  Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk.

Authors:  Lawrence M Wein; Yifan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

2.  Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.

Authors:  S U Nayak; J M Griffiss; R McKenzie; E J Fuchs; R A Jurao; A T An; A Ahene; M Tomic; C W Hendrix; J M Zenilman
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

3.  Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein.

Authors:  Q Meng; M Li; M A Silberg; F Conrad; J Bettencourt; R To; C Huang; J Ma; K Meyer; R Shimizu; L Cao; M T Tomic; J D Marks
Journal:  Anal Biochem       Date:  2011-10-06       Impact factor: 3.365

4.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30

5.  Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Authors:  Q Meng; C Garcia-Rodriguez; G Manzanarez; M A Silberg; F Conrad; J Bettencourt; X Pan; T Breece; R To; M Li; D Lee; L Thorner; M T Tomic; J D Marks
Journal:  Anal Biochem       Date:  2012-08-21       Impact factor: 3.365

6.  Centrifugal microfluidic platform for ultrasensitive detection of botulinum toxin.

Authors:  Chung-Yan Koh; Ulrich Y Schaff; Matthew E Piccini; Larry H Stanker; Luisa W Cheng; Easwaran Ravichandran; Bal-Ram Singh; Greg J Sommer; Anup K Singh
Journal:  Anal Chem       Date:  2015-01-05       Impact factor: 6.986

7.  Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.

Authors:  J T Guptill; S M Raja; V C Juel; E B Walter; M Cohen-Wolkowiez; H Hill; E Sendra; B Hauser; P Jackson; G K Swamy
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.